Zhejiang Hengtong Hits Day Low at CNY 9.49 Amid Price Pressure

Zhejiang Hengtong Holding Co., a prominent player in the Pharmaceuticals & Biotechnology sector, experienced a significant decline today, with its stock price dropping by 9.12%. The stock reached an intraday low of CNY 9.49, reflecting a challenging trading session. In terms of performance metrics, the company's one-day performance starkly contrasts with the China Shanghai Composite, which gained 1.16%. Over the past week, Zhejiang Hengtong has seen a decrease of 9.55%, while the composite index fell by 2.14%. However, the company has shown remarkable growth over the past month, with a 49.77% increase compared to a modest 0.13% rise in the composite index. Looking at longer-term performance, Zhejiang Hengtong has achieved a remarkable 253.14% increase over the past year, significantly outperforming the China Shanghai Composite's 18.97%. Despite these gains, the company faces challenges, including a high debt-equity ratio of 8.99% and rising raw material costs, which have increased by 32.65% year-over-year. The current market capitalization stands at CNY 21,027 million, indicating its large-cap status in the industry.